Community Academic Profiles–

Mark Hlatky, MD

Back to Profile

Publication Details

  • Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.

    Sanders GD, Hlatky MA, Every NR, McDonald KM, Heidenreich PA, Parsons LS, Owens DK. Ann Intern Med. 2001; 135 (10): 870-83

    Clinical trials have shown that implantable cardioverter defibrillators (ICDs) improve survival in patients with sustained ventricular arrhythmias.

    PubMedID: 11712877

Stanford Medicine Resources:

Footer Links: